Neurotech International Limited (NTI.AX)
AUD 0.05
(-3.57%)
AUD 0.05
(-3.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -2.11 Million AUD | -286.13% |
| 2023 | -3.01 Million AUD | -60.11% |
| 2022 | -1.88 Million AUD | 61.05% |
| 2021 | -4.82 Million AUD | -11636.86% |
| 2020 | 41.84 Thousand AUD | 112.0% |
| 2019 | -348.6 Thousand AUD | 84.03% |
| 2018 | -2.18 Million AUD | 3.52% |
| 2017 | -2.26 Million AUD | 63.07% |
| 2016 | -6.12 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -4.46 Million AUD | 0.0% |
| 2024 FY | -2.11 Million AUD | 29.9% |
| 2024 Q4 | -2.11 Million AUD | 0.0% |
| 2023 Q4 | -3.01 Million AUD | 0.0% |
| 2023 FY | -3.01 Million AUD | -60.11% |
| 2023 Q2 | -8.08 Million AUD | 0.0% |
| 2022 Q4 | -1.89 Million AUD | 0.0% |
| 2022 FY | -1.88 Million AUD | 61.05% |
| 2022 Q2 | -2.99 Million AUD | 0.0% |
| 2021 FY | -4.82 Million AUD | -11636.86% |
| 2021 Q4 | -4.82 Million AUD | 0.0% |
| 2021 Q2 | -2.01 Million AUD | 0.0% |
| 2020 Q2 | 166.42 Thousand AUD | 0.0% |
| 2020 Q4 | 41.84 Thousand AUD | 0.0% |
| 2020 FY | 41.84 Thousand AUD | 112.0% |
| 2019 FY | -348.6 Thousand AUD | 84.03% |
| 2019 Q4 | -348.6 Thousand AUD | 0.0% |
| 2019 Q2 | -411.53 Thousand AUD | 0.0% |
| 2018 Q4 | -2.18 Million AUD | 0.0% |
| 2018 Q2 | -4.16 Million AUD | 0.0% |
| 2018 FY | -2.18 Million AUD | 3.52% |
| 2017 Q2 | -4.1 Million AUD | 0.0% |
| 2017 FY | -2.26 Million AUD | 63.07% |
| 2017 Q4 | -2.26 Million AUD | 0.0% |
| 2016 Q4 | -61.92 Thousand AUD | 0.0% |
| 2016 FY | -6.12 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 91.719% |
| Adherium Limited | -6.1 Million AUD | 65.427% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 43.678% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 41.43% |
| Anteris Technologies Ltd | -28.49 Million AUD | 92.595% |
| Control Bionics Limited | -19.02 Thousand AUD | -10994.943% |
| CardieX Limited | 2.74 Million AUD | 176.848% |
| Compumedics Limited | 5.08 Million AUD | 141.488% |
| Cochlear Limited | -269.9 Million AUD | 99.218% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 402.105% |
| Cyclopharm Limited | -7.49 Million AUD | 71.857% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 86.558% |
| Nova Eye Medical Limited | -2.8 Million AUD | 24.68% |
| HeraMED Limited | -799.34 Thousand AUD | -164.025% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 114.572% |
| ImpediMed Limited | -23.48 Million AUD | 91.015% |
| InhaleRx Limited | -155.54 Thousand AUD | -1256.838% |
| LBT Innovations Limited | -604 Thousand AUD | -249.417% |
| Micro-X Limited | 826.99 Thousand AUD | 355.197% |
| OncoSil Medical Limited | -4.43 Million AUD | 52.367% |
| PolyNovo Limited | -30.52 Million AUD | 93.087% |
| Respiri Limited | 413.68 Thousand AUD | 610.161% |
| SomnoMed Limited | -15.16 Million AUD | 86.081% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 60.209% |
| Uscom Limited | -1.53 Million AUD | -37.883% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 48.31% |